Regsitration is now open for the fourth and final event in the EU Marie Curie Actions-sponsored conference series "Translational Research in Paediatric Rheumatology" (TRiPR) - Biological Agents and Emerging Treatments in the Management of Rheumatic Diseases - scheduled to be held this coming May 27th – 30th, 2010 in Genoa, Italy.

The final conference in the TRiPR series will address the treatment of both adult and childhood rheumatic diseases with the purpose of reviewing and discussing the progress that has been achieved thus far, the unmet needs that are still faced, and the potential new treatments that the future holds in store. A final session will be devoted to strategies to improve methodologies of translational research on and clinical development in common, as well as rare, forms of rheumatic disorders.

Interested participants are invited to submit abstracts - deadline: April 16, 2010 - on the following topics:

- Assessing drug response in chronic arthritis
- Biological agents in rheumatoid arthritis
- Biological agents in juvenile idiopathic arthritis
- Present and future therapies
- Potential new targets for treatment
- Facilitating translational research and clinical development in small populations

Eligible candidates are reminded that as many as 75 Marie Curie Grants covering conference registration fees, local accommodations and travel expenses will be awarded on a competitive basis to the authors of selected abstracts.

For further information and full details go to www.tripr.sispge.com